Prosecution Insights
Last updated: April 19, 2026
Application No. 17/922,089

SELECTIVE HYDROGENATION CATALYST COMPRISING A PARTICULAR DISTRIBUTION OF NICKEL AND MOYBDENUM

Non-Final OA §103
Filed
Oct 28, 2022
Examiner
NGUYEN, TAM M
Art Unit
1771
Tech Center
1700 — Chemical & Materials Engineering
Assignee
IFP Energies Nouvelles
OA Round
5 (Non-Final)
78%
Grant Probability
Favorable
5-6
OA Rounds
2y 9m
To Grant
88%
With Interview

Examiner Intelligence

Grants 78% — above average
78%
Career Allow Rate
746 granted / 963 resolved
+12.5% vs TC avg
Moderate +11% lift
Without
With
+10.9%
Interview Lift
resolved cases with interview
Typical timeline
2y 9m
Avg Prosecution
68 currently pending
Career history
1031
Total Applications
across all art units

Statute-Specific Performance

§101
0.1%
-39.9% vs TC avg
§103
51.2%
+11.2% vs TC avg
§102
16.7%
-23.3% vs TC avg
§112
18.7%
-21.3% vs TC avg
Black line = Tech Center average estimate • Based on career data from 963 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . In view of the appeal brief, filed on 1/20/2026, PROSECUTION IS HEREBY REOPENED. A new ground of rejection is set forth below. To avoid abandonment of the application, appellant must exercise one of the following two options: (1) file a reply under 37 CFR 1.111 (if this Office action is non-final) or a reply under 37 CFR 1.113 (if this Office action is final); or, (2) request reinstatement of the appeal. If reinstatement of the appeal is requested, such request must be accompanied by a supplemental appeal brief, but no new amendments, affidavits (37 CFR 1.130, 1.131 or 1.132) or other evidence are permitted. See 37 CFR 1.193(b)(2). A Supervisory Patent Examiner (SPE) has approved of reopening prosecution by signing below: /PREM C SINGH/ Supervisory Patent Examiner, Art Unit 1771 Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claims 1, 2, 4-6, 8, 10, 18, and 20-24 are rejected under 35 U.S.C. 103 as being unpatentable over Fécant et al. (US 8,841,231 B2) in view of Daudin et al. (US 2013/0261357 A1). Fécant et al. discloses a selective hydrogenation catalyst supported on porous alumina and comprising nickel (a Group VIII metal) as an active metal (see Fécant Examples 1–4). Fécant further teaches that the active metal is preferentially localized in a peripheral (egg-shell/crust) region of the alumina support and that the radial distribution of the metal is measured using an electron microprobe (Castaing-type microprobe) by acquiring concentration profiles from the outer surface toward the center of the catalyst particle (see Fécant Example 10 and Figure 6). Fécant defines crust thickness as the distance from the outer surface containing 80 wt.% of the metal and discloses crust thicknesses in the hundreds of micrometers range (see Fécant Example 10 and Table 2). Fécant also discloses alumina supports having BET surface areas overlapping the claimed 110–190 m²/g range (e.g., about 140 m²/g) and explicitly discloses an alumina support having a porous volume of 1.02 mL/g (1.02 cm³/g), which falls within the claimed 0.3–1.1 cm³/g total pore-volume range (see Fécant, catalyst preparation examples describing the alumina support properties, cols. 13–14). Fécant further explains that peripheral localization of the active metal improves hydrogenation selectivity by limiting diffusion into the core of the catalyst particle (see Fécant Example 10 discussion; also see col. 4, lines 62-66; col. 5, lines 25-45; col. 8, lines 41-57). Fécant does not teach the catalyst comprised a metal of Group VIB and the ratio of Ni/Mo. Daudin et al. discloses selective hydrogenation catalysts comprising an active phase containing a Group VIB metal (molybdenum) and a Group VIII metal (nickel) supported on alumina, wherein the Group VIB metal content and Group VIII metal content, measured in oxide form, overlap the ranges recited in claim 1 (see Daudin ¶¶ [0018]–[0023]). Daudin further discloses Ni/Mo molar ratios overlapping the claimed range (see Daudin ¶ [0021]) and teaches depositing the metals on the alumina support by impregnation (see Daudin ¶¶ [0050]–[0055]). It would have been obvious to one having ordinary skill in the art, before the effective filing date of the claimed invention, to modify the nickel-based, alumina-supported egg-shell catalyst architecture of Fécant et al. by incorporating the Group VIB metal (molybdenum) and Ni/Mo loadings taught by Daudin et al., because both references are directed to selective hydrogenation catalysts, Fécant teaches that peripheral metal localization verified by electron microprobe analysis improves hydrogenation selectivity, and Daudin teaches that Ni/Mo active phases on alumina are effective for selective hydrogenation, such that the modification represents a predictable use of prior-art elements according to their established functions (KSR Int’l Co. v. Teleflex Inc., 550 U.S. 398 (2007)). Claim 2 Fécant et al. teaches defining a peripheral “crust” as the region containing 80 wt.% of an active metal and discloses catalysts in which at least 80 wt.% of the active metal is localized in the crust (Fécant, Example 10; Table 2). Daudin et al. teaches Ni/Mo selective hydrogenation catalysts in which molybdenum (a Group VIB metal) is less mobile than nickel during impregnation and post-impregnation treatment, and that the distribution of molybdenum significantly affects catalytic selectivity (Daudin, ¶¶ [0018]–[0023], [0050]–[0055]). A person of ordinary skill in the art would therefore have found it obvious to apply the peripheral localization strategy taught by Fécant to the Group VIB metal (molybdenum) in the Ni/Mo catalyst system of Daudin, resulting in at least 80 wt.% of the Group VIB metal being distributed in a peripheral crust, as recited in claim 2. Claims 4–6 and 8 Further limitations on metal ratios and contents are obvious refinements of the Daudin active phase combined with the Fécant crust-type catalyst structure (Fécant Example 10). Claim 10 Ni/Mo active phase explicitly taught by Daudin ¶¶ [0018]–[0021]. Claim 18 Crust thickness 500–800 µm overlaps the thicknesses disclosed in Fécant Example 10; Table 2. Claim 20 Total pore volume 0.3–1.1 cm³/g overlaps Fécant Table 1. Claims 21–24 Metal contents and pore-volume fractions are obvious optimizations in view of Fécant’s controlled-porosity supports (Examples 1–4; Table 1) combined with Daudin’s Ni/Mo chemistry. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to TAM M NGUYEN whose telephone number is (571)272-1452. The examiner can normally be reached Mon - Frid. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Prem C Singh can be reached at 571-273-6381. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /TAM M NGUYEN/Primary Examiner, Art Unit 1771
Read full office action

Prosecution Timeline

Oct 28, 2022
Application Filed
Aug 10, 2024
Non-Final Rejection — §103
Sep 23, 2024
Response Filed
Dec 21, 2024
Final Rejection — §103
Feb 27, 2025
Response after Non-Final Action
Mar 12, 2025
Request for Continued Examination
Mar 13, 2025
Response after Non-Final Action
Mar 14, 2025
Non-Final Rejection — §103
Jul 18, 2025
Response Filed
Sep 30, 2025
Final Rejection — §103
Dec 01, 2025
Notice of Allowance
Jan 20, 2026
Response after Non-Final Action
Jan 27, 2026
Response after Non-Final Action
Jan 28, 2026
Non-Final Rejection — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12595428
PROCESS FOR DEPOLYMERIZATION OF SOLID MIXED PLASTIC
2y 5m to grant Granted Apr 07, 2026
Patent 12589376
CATALYTIC REACTOR FOR CRACKING WAX IN WASTE PLASTIC PROLYSIS PROCESS, CATALYTIC COMPOSITION FOR CRACKING WAX IN WASTE PLASTIC PYROLYSIS PROCESS, AND PRODUCTION METHOD THEREOF
2y 5m to grant Granted Mar 31, 2026
Patent 12589362
SUPPORT, ZEOLITE MEMBRANE COMPLEX, METHOD OF PRODUCING ZEOLITE MEMBRANE COMPLEX, AND SEPARATION METHOD
2y 5m to grant Granted Mar 31, 2026
Patent 12584070
METALLIC BASED HYDROCARBON PYROLYSIS
2y 5m to grant Granted Mar 24, 2026
Patent 12570588
DISTILLATE HYDROCRACKING PROCESS WITH A REVERSE ISOMERIZATION STEP TO INCREASE A CONCENTRATION OF N-PARAFFINS
2y 5m to grant Granted Mar 10, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

5-6
Expected OA Rounds
78%
Grant Probability
88%
With Interview (+10.9%)
2y 9m
Median Time to Grant
High
PTA Risk
Based on 963 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month